Cargando…

Common Variants at 10 Genomic Loci Influence Hemoglobin A(1C) Levels via Glycemic and Nonglycemic Pathways

OBJECTIVE: Glycated hemoglobin (HbA(1c)), used to monitor and diagnose diabetes, is influenced by average glycemia over a 2- to 3-month period. Genetic factors affecting expression, turnover, and abnormal glycation of hemoglobin could also be associated with increased levels of HbA(1c). We aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Soranzo, Nicole, Sanna, Serena, Wheeler, Eleanor, Gieger, Christian, Radke, Dörte, Dupuis, Josée, Bouatia-Naji, Nabila, Langenberg, Claudia, Prokopenko, Inga, Stolerman, Elliot, Sandhu, Manjinder S., Heeney, Matthew M., Devaney, Joseph M., Reilly, Muredach P., Ricketts, Sally L.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992787/
https://www.ncbi.nlm.nih.gov/pubmed/20858683
http://dx.doi.org/10.2337/db10-0502
_version_ 1782192781925548032
author Soranzo, Nicole
Sanna, Serena
Wheeler, Eleanor
Gieger, Christian
Radke, Dörte
Dupuis, Josée
Bouatia-Naji, Nabila
Langenberg, Claudia
Prokopenko, Inga
Stolerman, Elliot
Sandhu, Manjinder S.
Heeney, Matthew M.
Devaney, Joseph M.
Reilly, Muredach P.
Ricketts, Sally L.
author_facet Soranzo, Nicole
Sanna, Serena
Wheeler, Eleanor
Gieger, Christian
Radke, Dörte
Dupuis, Josée
Bouatia-Naji, Nabila
Langenberg, Claudia
Prokopenko, Inga
Stolerman, Elliot
Sandhu, Manjinder S.
Heeney, Matthew M.
Devaney, Joseph M.
Reilly, Muredach P.
Ricketts, Sally L.
author_sort Soranzo, Nicole
collection PubMed
description OBJECTIVE: Glycated hemoglobin (HbA(1c)), used to monitor and diagnose diabetes, is influenced by average glycemia over a 2- to 3-month period. Genetic factors affecting expression, turnover, and abnormal glycation of hemoglobin could also be associated with increased levels of HbA(1c). We aimed to identify such genetic factors and investigate the extent to which they influence diabetes classification based on HbA(1c) levels. RESEARCH DESIGN AND METHODS: We studied associations with HbA(1c) in up to 46,368 nondiabetic adults of European descent from 23 genome-wide association studies (GWAS) and 8 cohorts with de novo genotyped single nucleotide polymorphisms (SNPs). We combined studies using inverse-variance meta-analysis and tested mediation by glycemia using conditional analyses. We estimated the global effect of HbA(1c) loci using a multilocus risk score, and used net reclassification to estimate genetic effects on diabetes screening. RESULTS: Ten loci reached genome-wide significant association with HbA(1c), including six new loci near FN3K (lead SNP/P value, rs1046896/P = 1.6 × 10(−26)), HFE (rs1800562/P = 2.6 × 10(−20)), TMPRSS6 (rs855791/P = 2.7 × 10(−14)), ANK1 (rs4737009/P = 6.1 × 10(−12)), SPTA1 (rs2779116/P = 2.8 × 10(−9)) and ATP11A/TUBGCP3 (rs7998202/P = 5.2 × 10(−9)), and four known HbA(1c) loci: HK1 (rs16926246/P = 3.1 × 10(−54)), MTNR1B (rs1387153/P = 4.0 × 10(−11)), GCK (rs1799884/P = 1.5 × 10(−20)) and G6PC2/ABCB11 (rs552976/P = 8.2 × 10(−18)). We show that associations with HbA(1c) are partly a function of hyperglycemia associated with 3 of the 10 loci (GCK, G6PC2 and MTNR1B). The seven nonglycemic loci accounted for a 0.19 (% HbA(1c)) difference between the extreme 10% tails of the risk score, and would reclassify ∼2% of a general white population screened for diabetes with HbA(1c). CONCLUSIONS: GWAS identified 10 genetic loci reproducibly associated with HbA(1c). Six are novel and seven map to loci where rarer variants cause hereditary anemias and iron storage disorders. Common variants at these loci likely influence HbA(1c) levels via erythrocyte biology, and confer a small but detectable reclassification of diabetes diagnosis by HbA(1c).
format Text
id pubmed-2992787
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-29927872011-12-01 Common Variants at 10 Genomic Loci Influence Hemoglobin A(1C) Levels via Glycemic and Nonglycemic Pathways Soranzo, Nicole Sanna, Serena Wheeler, Eleanor Gieger, Christian Radke, Dörte Dupuis, Josée Bouatia-Naji, Nabila Langenberg, Claudia Prokopenko, Inga Stolerman, Elliot Sandhu, Manjinder S. Heeney, Matthew M. Devaney, Joseph M. Reilly, Muredach P. Ricketts, Sally L. Diabetes Pharmacology and Therapeutics OBJECTIVE: Glycated hemoglobin (HbA(1c)), used to monitor and diagnose diabetes, is influenced by average glycemia over a 2- to 3-month period. Genetic factors affecting expression, turnover, and abnormal glycation of hemoglobin could also be associated with increased levels of HbA(1c). We aimed to identify such genetic factors and investigate the extent to which they influence diabetes classification based on HbA(1c) levels. RESEARCH DESIGN AND METHODS: We studied associations with HbA(1c) in up to 46,368 nondiabetic adults of European descent from 23 genome-wide association studies (GWAS) and 8 cohorts with de novo genotyped single nucleotide polymorphisms (SNPs). We combined studies using inverse-variance meta-analysis and tested mediation by glycemia using conditional analyses. We estimated the global effect of HbA(1c) loci using a multilocus risk score, and used net reclassification to estimate genetic effects on diabetes screening. RESULTS: Ten loci reached genome-wide significant association with HbA(1c), including six new loci near FN3K (lead SNP/P value, rs1046896/P = 1.6 × 10(−26)), HFE (rs1800562/P = 2.6 × 10(−20)), TMPRSS6 (rs855791/P = 2.7 × 10(−14)), ANK1 (rs4737009/P = 6.1 × 10(−12)), SPTA1 (rs2779116/P = 2.8 × 10(−9)) and ATP11A/TUBGCP3 (rs7998202/P = 5.2 × 10(−9)), and four known HbA(1c) loci: HK1 (rs16926246/P = 3.1 × 10(−54)), MTNR1B (rs1387153/P = 4.0 × 10(−11)), GCK (rs1799884/P = 1.5 × 10(−20)) and G6PC2/ABCB11 (rs552976/P = 8.2 × 10(−18)). We show that associations with HbA(1c) are partly a function of hyperglycemia associated with 3 of the 10 loci (GCK, G6PC2 and MTNR1B). The seven nonglycemic loci accounted for a 0.19 (% HbA(1c)) difference between the extreme 10% tails of the risk score, and would reclassify ∼2% of a general white population screened for diabetes with HbA(1c). CONCLUSIONS: GWAS identified 10 genetic loci reproducibly associated with HbA(1c). Six are novel and seven map to loci where rarer variants cause hereditary anemias and iron storage disorders. Common variants at these loci likely influence HbA(1c) levels via erythrocyte biology, and confer a small but detectable reclassification of diabetes diagnosis by HbA(1c). American Diabetes Association 2010-12 2010-09-21 /pmc/articles/PMC2992787/ /pubmed/20858683 http://dx.doi.org/10.2337/db10-0502 Text en © 2010 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Pharmacology and Therapeutics
Soranzo, Nicole
Sanna, Serena
Wheeler, Eleanor
Gieger, Christian
Radke, Dörte
Dupuis, Josée
Bouatia-Naji, Nabila
Langenberg, Claudia
Prokopenko, Inga
Stolerman, Elliot
Sandhu, Manjinder S.
Heeney, Matthew M.
Devaney, Joseph M.
Reilly, Muredach P.
Ricketts, Sally L.
Common Variants at 10 Genomic Loci Influence Hemoglobin A(1C) Levels via Glycemic and Nonglycemic Pathways
title Common Variants at 10 Genomic Loci Influence Hemoglobin A(1C) Levels via Glycemic and Nonglycemic Pathways
title_full Common Variants at 10 Genomic Loci Influence Hemoglobin A(1C) Levels via Glycemic and Nonglycemic Pathways
title_fullStr Common Variants at 10 Genomic Loci Influence Hemoglobin A(1C) Levels via Glycemic and Nonglycemic Pathways
title_full_unstemmed Common Variants at 10 Genomic Loci Influence Hemoglobin A(1C) Levels via Glycemic and Nonglycemic Pathways
title_short Common Variants at 10 Genomic Loci Influence Hemoglobin A(1C) Levels via Glycemic and Nonglycemic Pathways
title_sort common variants at 10 genomic loci influence hemoglobin a(1c) levels via glycemic and nonglycemic pathways
topic Pharmacology and Therapeutics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992787/
https://www.ncbi.nlm.nih.gov/pubmed/20858683
http://dx.doi.org/10.2337/db10-0502
work_keys_str_mv AT soranzonicole commonvariantsat10genomiclociinfluencehemoglobina1clevelsviaglycemicandnonglycemicpathways
AT sannaserena commonvariantsat10genomiclociinfluencehemoglobina1clevelsviaglycemicandnonglycemicpathways
AT wheelereleanor commonvariantsat10genomiclociinfluencehemoglobina1clevelsviaglycemicandnonglycemicpathways
AT giegerchristian commonvariantsat10genomiclociinfluencehemoglobina1clevelsviaglycemicandnonglycemicpathways
AT radkedorte commonvariantsat10genomiclociinfluencehemoglobina1clevelsviaglycemicandnonglycemicpathways
AT dupuisjosee commonvariantsat10genomiclociinfluencehemoglobina1clevelsviaglycemicandnonglycemicpathways
AT bouatianajinabila commonvariantsat10genomiclociinfluencehemoglobina1clevelsviaglycemicandnonglycemicpathways
AT langenbergclaudia commonvariantsat10genomiclociinfluencehemoglobina1clevelsviaglycemicandnonglycemicpathways
AT prokopenkoinga commonvariantsat10genomiclociinfluencehemoglobina1clevelsviaglycemicandnonglycemicpathways
AT stolermanelliot commonvariantsat10genomiclociinfluencehemoglobina1clevelsviaglycemicandnonglycemicpathways
AT sandhumanjinders commonvariantsat10genomiclociinfluencehemoglobina1clevelsviaglycemicandnonglycemicpathways
AT heeneymatthewm commonvariantsat10genomiclociinfluencehemoglobina1clevelsviaglycemicandnonglycemicpathways
AT devaneyjosephm commonvariantsat10genomiclociinfluencehemoglobina1clevelsviaglycemicandnonglycemicpathways
AT reillymuredachp commonvariantsat10genomiclociinfluencehemoglobina1clevelsviaglycemicandnonglycemicpathways
AT rickettssallyl commonvariantsat10genomiclociinfluencehemoglobina1clevelsviaglycemicandnonglycemicpathways